Jaguar Health Inc (NASDAQ:JAGX)’s traded shares stood at 1.6 million during the last session, with the company’s beta value hitting 0.80. At the close of trading, the stock’s price was $0.58, to imply a decrease of -15.59% or -$0.1 in intraday trading. The JAGX share’s 52-week high remains $21.60, putting it -3624.14% down since that peak but still an impressive -15.52% since price per share fell to its 52-week low of $0.67.
Analysts have given a consensus recommendation of Buy for Jaguar Health Inc (JAGX), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give JAGX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.74.
Jaguar Health Inc (NASDAQ:JAGX) trade information
After registering a -15.59% downside in the last session, Jaguar Health Inc (JAGX) has traded red over the past five days. The 5-day price performance for the stock is -34.68%, and -38.62% over 30 days. With these gigs, the year-to-date price performance is -43.00%.
Revenue forecast for the current quarter as set by 1 analysts is 3.13M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 3.29M.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 86.10% for the past 5-year period. While 2025 is set for a 99.26% return in earnings, projections for the next 5 years are at 79.17% annually.
JAGX Dividends
Jaguar Health Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Jaguar Health Inc (JAGX) shares. Going by data provided on Sep 30, 2024 , Vanguard Extended Market Index Fund holds roughly 59.5 shares. This is just over 0.36% of the total shares, with a market valuation of $34255.0. Data from the same date shows that the other fund manager holds a little less at 50.91, or 0.31% of the shares, all valued at about 29306.0.
